Board Meeting7 May 2026, 07:51 pm
Vijaya Diagnostic Recommends ₹2 Dividend; Reddy Not Seeking Re-Appointment
AI Summary
Vijaya Diagnostic Centre Ltd's board approved the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. A final dividend of ₹2 per equity share (200% on face value of ₹1) was recommended, subject to shareholder approval. Dr. D Nageshwar Reddy will not seek re-appointment as an Independent Director. M/s. Santhosh & Associates were re-appointed as Cost Auditors for FY 2026-27. The company also granted 1,79,500 ESOPs and approved the acquisition of MRI, EEG, and NCV Services Business from Medinova Millennium MRI Services LLP.
Key Highlights
- Final dividend of ₹2 per share recommended for FY26, subject to shareholder approval.
- Dr. D Nageshwar Reddy will not seek a second term as Independent Director.
- Santhosh & Associates re-appointed as Cost Auditors for FY 2026-27.
- 1,79,500 Employee Stock Options (ESOPs) granted under VDCL Employee Stock Option Plan 2018.
- Acquisition of MRI, EEG, and NCV Services Business from Medinova Millennium MRI Services LLP approved.
Price Impact
More from VIJAYA